Literature DB >> 11349303

Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment.

K Yoshimura1, K Harii, Y Masuda, M Takahashi, T Aoyama, T Iga.   

Abstract

As a depigmenting treatment, combined topical applications of all-trans retinoic acid (atRA) aqueous gel and 5% hydroquinone, 7% lactic acid ointment were used for Oriental patients with hyperpigmented skin lesions such as senile lentigines and nevus spilus. A narrow-band reflectance spectrophotometer and a tristimulus colorimeter were used to evaluate objectively the intensity of pigmentation and erythema at each clinical visit. L*, a*, and b* values measured with a tristimulus colorimeter (Chroma Meter CR-300) enabled the evaluation of erythema but not pigmentation. On the other hand, the melanin and hemoglobin values measured with a narrow-band reflectance spectrophotometer (Mexameter MX-16) expressed both erythema and pigmentation well. It was revealed that, in our bleaching protocol, the narrow-band reflectance spectrophotometer was quite useful for estimating accurately the intensity of pigmentation and erythema and determining the best time point for the cessation of atRA treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349303     DOI: 10.1007/s002660010109

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  2 in total

1.  Vitiligo Coexistent with Nevus Depigmentosus: This Was Treated with Narrow-Band UVB and These Lesions Were Followed Using the Mexameter®, a Pigment-Measuring Device.

Authors:  Seon-Wook Hwang; Ju-Hyun Kang; So-Young Jung; Joon-Hee Choi; Jong-Keun Seo; Deborah Lee; Ho-Suk Sung
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  Comparative Measurement of Biophysical Parameters in Consideration of Skin Graft Donor Site for Nasal Defects.

Authors:  Joo-Hak Kim; Chang Hwan Ahn; Sungmin Kim; Young Lee; Sang-Ha Oh
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.